Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-13
Clinical Trial Update: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) [Phase 1, Phase 2]
This update describes BEAM-201, a study in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, in Pha…